EGFR and non-small cell lung carcinoma: Kei Kunimasa conducted a comprehensive statistical analysis encompassing 123 patients diagnosed with advanced NSCLC and EGFR mutations at the International Cancer Institute, Osaka, spanning the period from 2014 to 2019.